Your joints are inflamed, stiff, and slowly losing ground. Whether it's autoimmune or wear-and-tear, the result is the same — your body is breaking down cartilage faster than it can rebuild it.
NSAIDs and corticosteroids manage inflammation and pain but don't slow joint destruction. DMARDs and biologics (methotrexate, TNF inhibitors) can slow rheumatoid arthritis progression but carry significant immunosuppression risks. For osteoarthritis, the options are thinner — physical therapy, weight management, and eventually joint replacement. Hyaluronic acid injections and PRP have mixed evidence. The underlying inflammatory cascade continues regardless.
Barilaro et al. (2021) published a study in the International Journal of Molecular Sciences demonstrating that HBOT at 1.5 ATA reduced inflammatory cytokines (TNF-alpha, IL-6, IL-1beta) and increased anti-inflammatory IL-10 in patients with inflammatory conditions. This cytokine modulation directly addresses the molecular drivers of both rheumatoid and osteoarthritis.1
Vaillancourt et al. (2015) showed in The Journal of Rheumatology that HBOT at 1.5 ATA significantly reduced joint swelling and cartilage degradation markers in an animal model of inflammatory arthritis. Histological analysis confirmed preservation of articular cartilage and reduced synovial inflammation.2
Efrati et al. (2018) demonstrated in a study published in Aging that HBOT at 1.5 ATA modulated senescent cell clearance and reduced systemic inflammatory markers — mechanisms directly relevant to the chronic low-grade inflammation that drives osteoarthritis progression in aging joints.3
Alves et al. (2013) published a randomized controlled trial in Lasers in Medical Science showing that near-infrared photobiomodulation at 850 nm applied to osteoarthritic knees produced significant reductions in pain and improvements in joint function (WOMAC scores) compared to placebo, with effects lasting beyond the treatment period.4
Hamblin et al. (2017) reviewed the PBM literature for arthritis in Dose-Response, concluding that near-infrared wavelengths (810–850 nm) reduce joint inflammation by suppressing NF-kB signaling and decreasing reactive oxygen species. The anti-inflammatory effect was consistent across both rheumatoid and osteoarthritis studies.5
Alfredo et al. (2012) demonstrated in Lasers in Surgery and Medicine that 808 nm laser therapy combined with exercise produced greater pain relief and functional improvement than exercise alone in knee osteoarthritis patients, with measurable reductions in joint effusion on ultrasound imaging.6